Registration - In-house Corporation

Pharmascience Inc. / Martin Arès, Chief Executive Officer

Registration Information

In-house Corporation name: Pharmascience Inc.
Responsible Officer Name: Martin Arès, Chief Executive Officer
Responsible Officer Change History
Initial registration start date: 2009-02-02
Registration status: Active
Registration Number: 953865-234102

Associated Communications

Total Number of Communication Reports: 53

Monthly communication reports in the last 6 months: 0

Version 12 of 22 (2021-01-20 to 2021-01-20)

Registration versions:

Version 12 of 22 (2021-01-20 to 2021-01-20)

Lobbying Information

Subject Matters

Economic Development
Government Procurement
Health
Industry
Intellectual Property
International Trade
Municipalities
Regional Development
Research and Development
Science and Technology
Taxation and Finance

Subject Matter Details

Policies or Program

Discussion of Pharmascience Inc. ("PMS") trade difficulties in the Kingdom of Saudi Arabia ("KSA") resulting from the trade relations between Canada and the KSA. Understanding of government actions to resolve the issue, and of when PMS might expect to re-gain business opportunities in the region.
Discussion of a possible Therapeutics Products Directorate ("TPD") workstream on complex generics regulatory pathways.
Discussion of regulatory impediments to the launch of pediatric formulations of branded and generic products.
Discussion on the opioids crisis and the Health minister's expectations from pharmaceutical manufacturers
Policies aimed at facilitating generic drugs repurposing.
Policies aimed at reinforcing pharmaceutical supply chain.

Communication Techniques

Written communication
Oral communication
Grass-roots communication

Government Institutions

Finance Canada (FIN)
Global Affairs Canada (GAC)
Health Canada (HC)
House of Commons
Innovation, Science and Economic Development Canada (ISED)

In-house Corporation Details

Description of activities

Pharmascience Inc. is a Canadian-owned pharmaceutical company specializing in the manufacturing and distribution of generic, innovative, and consumer brand pharmaceutical products in Canada

Responsible officer name and position during the period of this registration

David Goodman, Chief Executive Officer

Government funding

No government funding was received during the last completed financial year.

In-house Corporation Contact Information

Address:
6111 Royalmount avenue, suite 100
Montreal, QC H4P 2T4
Canada

Telephone number: 514-340-9800
Fax number: 514-342-3654

Parent Company Information

Joddes Limited
- 6111 Royalmount Avenue, suite 100
  Montreal, QC H4P 2T4
  Canada

Subsidiary Beneficiary Information

Pharmascience Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyists Details

Senior Officers whose lobbying activities represent less than 20% of their Duties

David Goodman, Chief Executive Officer | No public offices held
Morris Goodman, Owner and Chairman of the Board of Directors | No public offices held
Jean-Guy Goulet, Chief Operating Officer (COO) | No public offices held

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

Alain Boisvert, Head, Government Affairs & Market Access | No public offices held
Sarah E Douglas, Senior Manager Gouvernment Affairs | Public offices held

Pharmascience Inc.

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
Pharmascience Inc.	2009-02-02	current

Pharmascience Inc.

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)
Martin Arès	2023-01-03	Current
David Goodman	2009-02-02	2023-01-03

Martin Arès, Chief Executive Officer (Corporation)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15^th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-53 of 53

Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ritu Banerjee, Assistant Deputy Minister | Director General's Office | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Economic Development, Industry
Communication date: 2023-10-16
Posted date: 2023-10-18
Communication number: 234102-580022 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Simon Kennedy, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Economic Development, Industry
Communication date: 2023-06-13
Posted date: 2023-06-15
Communication number: 234102-569549 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Simon Kennedy, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry
Communication date: 2023-03-15
Posted date: 2023-03-27
Communication number: 234102-560613 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Stephen Ellis, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Economic Development, Industry
Communication date: 2023-02-16
Posted date: 2023-02-16
Communication number: 234102-556959 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jamee St-Hilaire, Québec Lieutenant's office | Health Canada (HC)
Subject Matter of the communication: Health, Industry
Communication date: 2022-11-10
Posted date: 2022-12-07
Communication number: 234102-549170 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Don Davies, Député | House of Commons
Subject Matter of the communication: Health, Industry
Communication date: 2022-11-03
Posted date: 2022-11-07
Communication number: 234102-545443 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Eric Costen, Assistant Deputy Minister, Industry, Science and Economic Development Canada | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry
Communication date: 2022-11-03
Posted date: 2022-11-07
Communication number: 234102-545442 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jamie Kippen, Chef de cabinet | Cabinet du ministre | Health Canada (HC)
Subject Matter of the communication: Health, Industry
Communication date: 2022-11-02
Posted date: 2022-11-07
Communication number: 234102-545441 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Bianca Hossain, Adjoint(e) principale spécial(e) | Innovation, Science and Economic Development Canada (ISED)
- Ian Foucher, Chef de cabinet | Cabinet du ministre de l'Innovation, des Sciences et de l'Industrie | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry
Communication date: 2022-11-02
Posted date: 2022-11-07
Communication number: 234102-545440 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Bianca Hossain, Sr Special Assistant | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry
Communication date: 2022-09-22
Posted date: 2022-09-27
Communication number: 234102-542310 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Anthony Housefather, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry
Communication date: 2022-08-23
Posted date: 2022-08-25
Communication number: 234102-540460 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Shaili Patel, Director of Policy | Minister's Office, Mental Health and Addictions | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2022-07-18
Posted date: 2022-07-20
Communication number: 234102-538695 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Bianca Hossain, Sr Special Assistant | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Economic Development, Industry
Communication date: 2022-07-05
Posted date: 2022-07-06
Communication number: 234102-536722 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Victor Kandasamy, Policy Advisor (Quebec) | Health Canada (HC)
- Sandenga Yeba, Senior Policy Advisor | Minister's Office | Health Canada (HC)
Subject Matter of the communication: Health, Industry
Communication date: 2022-07-05
Posted date: 2022-07-06
Communication number: 234102-536721 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Stephen Lucas, Deputy Minister | Health Canada (HC)
Subject Matter of the communication: Health, Industry
Communication date: 2022-06-21
Posted date: 2022-06-22
Communication number: 234102-536144 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Eric Costen, Assistant Deputy Minister, Industry, Science and Economic Development Canada | Innovation, Science and Economic Development Canada (ISED)
- Simon Kennedy, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Economic Development, Industry
Communication date: 2022-06-13
Posted date: 2022-06-20
Communication number: 234102-536048 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Majid Jowhari, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2022-05-26
Posted date: 2022-06-01
Communication number: 234102-533102 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Michael Barrett, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2022-04-28
Posted date: 2022-05-09
Communication number: 234102-530796 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Laila Goodridge, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2022-04-19
Posted date: 2022-04-19
Communication number: 234102-529875 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Sandenga Yeba, Senior Policy Advisor | Minister's Office | Health Canada (HC)
Subject Matter of the communication: Health, Industry
Communication date: 2022-04-13
Posted date: 2022-04-13
Communication number: 234102-528611 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Anthony Housefather, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Economic Development, Industry
Communication date: 2022-04-11
Posted date: 2022-04-12
Communication number: 234102-528286 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Matthew Stenson, Policy Advisor | Minister's Office, International Development | Global Affairs Canada (GAC)
Subject Matter of the communication: Health, Government Procurement
Communication date: 2022-03-22
Posted date: 2022-03-23
Communication number: 234102-526979 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Camille Benoit-Blouin, Policy Advisor | Minister's Office, International Trade | Global Affairs Canada (GAC)
- Laurence Harvey, Senior Policy Advisor | Minister's Office | Global Affairs Canada (GAC)
Subject Matter of the communication: International Trade, Health
Communication date: 2022-03-16
Posted date: 2022-03-16
Communication number: 234102-526743 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- David Hurl, Officer | Minister's Office | Innovation, Science and Economic Development Canada (ISED)
- Maaz Yasin, Advisor, Stakeholder Relations, Office of the Deputy Prime Minister | Prime Minister's Office (PMO)
Subject Matter of the communication: International Trade, Health
Communication date: 2022-03-10
Posted date: 2022-03-10
Communication number: 234102-524720 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Chris d'Entremont, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2022-02-08
Posted date: 2022-02-08
Communication number: 234102-521396 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Kaitlyn Forbes, Senior Policy Advisor, Minister’s Office, Minister of Mental Health and Addictions/Health Canada | Health Canada (HC)
- Shali Patel, Director of Policy, Minister’s Office, Minister of Mental Health and Addictions/Health Canada | Health Canada (HC)
Subject Matter of the communication: Health, Industry
Communication date: 2022-01-27
Posted date: 2022-01-28
Communication number: 234102-520740 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Eric Costen, Assistant Deputy Minister, Industry, Science and Economic Development Canada | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Economic Development, Industry
Communication date: 2022-01-20
Posted date: 2022-01-28
Communication number: 234102-520739 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Bianca Hossain, Sr Special Assistant | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Economic Development, Industry
Communication date: 2022-01-19
Posted date: 2022-01-28
Communication number: 234102-520738 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rafik Grine, Policy Advisor | Minister's Office | Global Affairs Canada (GAC)
Subject Matter of the communication: International Trade, Health
Communication date: 2021-07-21
Posted date: 2021-08-10
Communication number: 234102-512342 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Sara Wilshaw, Chief Trade Commissioner | International Business Develolpment, Investment, and Innovation | Global Affairs Canada (GAC)
Subject Matter of the communication: International Trade, Health
Communication date: 2021-07-21
Posted date: 2021-08-10
Communication number: 234102-512341 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Natacha Engel, Senior Policy Advisor | Minister's Office | Global Affairs Canada (GAC)
Subject Matter of the communication: International Trade, Health
Communication date: 2021-06-22
Posted date: 2021-06-22
Communication number: 234102-509352 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Helen Gao, Policy Advisor | Minister's Office | Global Affairs Canada (GAC)
Subject Matter of the communication: Health
Communication date: 2021-05-20
Posted date: 2021-06-04
Communication number: 234102-506777 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Luc Theriault, Member of Parliament | Minister's Office | House of Commons
Subject Matter of the communication: Health
Communication date: 2021-05-18
Posted date: 2021-05-19
Communication number: 234102-506166 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Chris D'Entremont, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2021-05-04
Posted date: 2021-05-04
Communication number: 234102-503576 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Philip Kuligowski Chan, Senior Policy Advisor | Minister's Office | Transport Canada (TC)
Subject Matter of the communication: International Trade, Health
Communication date: 2021-04-23
Posted date: 2021-04-30
Communication number: 234102-503365 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Philip Kuligowski Chan, Senior Policy Advisor | Minister's Office | Transport Canada (TC)
Subject Matter of the communication: International Trade, Health
Communication date: 2021-04-13
Posted date: 2021-04-14
Communication number: 234102-501742 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Celine Caira, Senior Policy Advisor | Minister's Office | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Industry, Science and Technology
Communication date: 2021-03-31
Posted date: 2021-04-01
Communication number: 234102-500454 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Michael D. Chong, Member of Parliament | House of Commons
Subject Matter of the communication: International Trade, Health
Communication date: 2021-03-16
Posted date: 2021-03-17
Communication number: 234102-499883 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Helen Gao, Policy Advisor | Minister's Office | Health Canada (HC)
- Tahiya Bakht, Senior Advisor | Minister's Office | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2021-03-03
Posted date: 2021-03-12
Communication number: 234102-498191 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ian Foucher, Director of Policy | Office of the Minister of Finance | Finance Canada (FIN)
Subject Matter of the communication: International Trade
Communication date: 2019-07-02
Posted date: 2019-07-04
Communication number: 234102-456701 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rachel Bendayan, MP Outremont | House of Commons
Subject Matter of the communication: International Trade, Health
Communication date: 2019-06-14
Posted date: 2019-07-04
Communication number: 234102-456700 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Omar Alghabra, Parliamentary Secretary to the Minister of International Trade | House of Commons
Subject Matter of the communication: International Trade
Communication date: 2019-06-03
Posted date: 2019-06-10
Communication number: 234102-454555 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jamie Inness, Deputy Chief of Staff | Office of the Minister of International Trade | Global Affairs Canada (GAC)
Subject Matter of the communication: International Trade
Communication date: 2019-04-24
Posted date: 2019-05-23
Communication number: 234102-453458 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- John Knubley, Deputy Minister | Industry Canada
- Philip Jennings, Assistant Deputy Minister | Industry Canada
Subject Matter of the communication: Industry, Intellectual Property, International Trade
Communication date: 2014-05-06
Posted date: 2014-06-16
Communication number: 234102-328027 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Paul Glover, Assistant Deputy Minister | Health Products and Food Branch | Health Canada (HC)
Subject Matter of the communication: Industry, Health
Communication date: 2013-06-03
Posted date: 2013-07-15
Communication number: 234102-280673 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Philip Jennings, Assistant Deputy Minister | Industry Sector, Industry Canada | Industry Canada
- John Knubley, Deputy Minister | Industry Canada
Subject Matter of the communication: Industry, Intellectual Property, International Trade
Communication date: 2012-11-19
Posted date: 2012-12-15
Communication number: 234102-249950 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Christian Paradis, Minister of Industry | Industry Canada
- Sean O'Leary, Policy Advisor | Office of the Minister | Industry Canada
- Margaux Stastny, Director of Communications | Office of the Minister | Industry Canada
Subject Matter of the communication: Industry, Intellectual Property, International Trade
Communication date: 2012-08-27
Posted date: 2012-09-15
Communication number: 234102-235550 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- John Baird, Minister of Foreign Affairs | Foreign Affairs and International Trade Canada (DFAITC)
- Oren Cainer, Senior Policy Advisor | Office of the Minister of Foreign Affairs | Foreign Affairs and International Trade Canada (DFAITC)
Subject Matter of the communication: Industry, Intellectual Property, International Trade
Communication date: 2012-07-23
Posted date: 2012-08-15
Communication number: 234102-233551 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Sean O'Leary, Policy Advisor | Office of the Minister | Industry Canada
- Christian Paradis, Minister of Industry | Industry Canada
Subject Matter of the communication: Industry, Intellectual Property, International Trade
Communication date: 2012-02-02
Posted date: 2012-03-23
Communication number: 234102-213527 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- John Connell, Sous-Ministre adjoint délégué | Industry Canada
- Philip Jennings, Associate Assistant Deputy Minister | Industry Canada
- Simon Kennedy, Senior Associate Deputy Minister | Industry Canada
Subject Matter of the communication: Industry, Intellectual Property, International Trade, Health
Communication date: 2011-11-03
Posted date: 2011-11-09
Communication number: 234102-192956 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Richard Dicerni, Deputy Minister | Industry Canada
Subject Matter of the communication: Industry, Intellectual Property, International Trade, Health
Communication date: 2011-11-03
Posted date: 2011-11-09
Communication number: 234102-192953 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rudy Husny, Press Secretary | Office of the Minister of International Trade | Foreign Affairs and International Trade Canada (DFAITC)
Subject Matter of the communication: Industry, Intellectual Property, International Trade, Health
Communication date: 2011-10-24
Posted date: 2011-11-09
Communication number: 234102-192950 View associated registration
Pharmascience Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ed Fast, Minister of International Trade | Foreign Affairs and International Trade Canada (DFAITC)
Subject Matter of the communication: Industry, Intellectual Property, International Trade, Health
Communication date: 2011-10-24
Posted date: 2011-11-09
Communication number: 234102-192945 View associated registration

List of Public Offices Held
Position	Period Held	Last Date Designated Public Office Held
Press Secretary (Ontario) House of Commons, Office of the Leader of t he Official Opposition	January 2013 to September 2013	Not a designated office
Press Secretary (Ontario) - Acting House of Commons, Office of the Leader of the Official Opposition	October 2012 to December 2012	Not a designated office
Communications Officer - Writer House of Commons, Office of the Leader of t he Official Opposition	February 2012 to September 2012	Not a designated office
Parliamentary Assistant House of Commons, Office of Jamie Nicholls, MP	July 2011 to February 2012	Not a designated office
Member's Assistant House of Commons, Office of Judy Wasylycia-Leis, MP	March 2010 to March 2010	Not a designated office
Research Assistant House of Commons, Office of John Rafferty, MP	September 2008 to March 2011	Not a designated office

List of Public Offices Held
Position	Period Held	Last Date Designated Public Office Held
Press Secretary (Ontario) House of Commons, Office of the Leader of t he Official Opposition	January 2013 to September 2013	Not a designated office
Press Secretary (Ontario) - Acting House of Commons, Office of the Leader of the Official Opposition	October 2012 to December 2012	Not a designated office
Communications Officer - Writer House of Commons, Office of the Leader of t he Official Opposition	February 2012 to September 2012	Not a designated office
Parliamentary Assistant House of Commons, Office of Jamie Nicholls, MP	July 2011 to February 2012	Not a designated office
Member's Assistant House of Commons, Office of Judy Wasylycia-Leis, MP	March 2010 to March 2010	Not a designated office
Research Assistant House of Commons, Office of John Rafferty, MP	September 2008 to March 2011	Not a designated office

Date Modified:: 2024-04-04

Search and menus

Language selection

Registration - In-house Corporation

Pharmascience Inc. / Martin Arès, Chief Executive Officer

Registration Information

Associated Communications

Version 12 of 22 (2021-01-20 to 2021-01-20)

Version 12 of 22 (2021-01-20 to 2021-01-20)

Subject Matters

Subject Matter Details

Policies or Program

Communication Techniques

Government Institutions

Description of activities

Responsible officer name and position during the period of this registration

Government funding

In-house Corporation Contact Information

Parent Company Information

Subsidiary Beneficiary Information

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties